Literature DB >> 28797314

Intravenous sotalol use in a complex critically ill child: balancing the systems in choosing antiarrhythmic medication.

Michele M Pasierb1, Stephen P Seslar1.   

Abstract

In critically ill children, multi-organ-system disease can influence the choice of antiarrhythmic medication. Intravenous therapy is often necessary. There is a scarcity of paediatric critical-care cases demonstrating the dosing, monitoring, and efficacy of intravenous sotalol. This case demonstrates the effective use of intravenous sotalol in an adolescent with renal, hepatic, and haematological dysfunctions.

Entities:  

Keywords:  Sotalol; atrial fibrillation; atrial flutter; intravenous; paediatric critical care

Mesh:

Substances:

Year:  2017        PMID: 28797314     DOI: 10.1017/S1047951117001408

Source DB:  PubMed          Journal:  Cardiol Young        ISSN: 1047-9511            Impact factor:   1.093


  3 in total

1.  Early experience with intravenous sotalol in children with and without congenital heart disease.

Authors:  Santiago O Valdés; Christina Y Miyake; Mary C Niu; Caridad M de la Uz; S Yukiko Asaki; Andrew P Landstrom; Andrew E Schneider; Craig G Rusin; Raajen Patel; Wilson W Lam; Jeffrey J Kim
Journal:  Heart Rhythm       Date:  2018-07-10       Impact factor: 6.343

2.  Intravenous sotalol for the management of postoperative junctional ectopic tachycardia.

Authors:  Santiago O Valdés; Andrew P Landstrom; Andrew E Schneider; Christina Y Miyake; Caridad M de la Uz; Jeffrey J Kim
Journal:  HeartRhythm Case Rep       Date:  2018-05-30

3.  IV Sotalol Use in Pediatric and Congenital Heart Patients: A Multicenter Registry Study.

Authors:  Lindsey E Malloy-Walton; Nicholas H Von Bergen; Seshadri Balaji; Peter S Fischbach; Jason M Garnreiter; S Yukiko Asaki; Jeffrey P Moak; Luis A Ochoa; Philip M Chang; Hoang H Nguyen; Akash R Patel; Christa Kirk; Ashley K Sherman; Jennifer N Avari Silva; J Philip Saul
Journal:  J Am Heart Assoc       Date:  2022-05-02       Impact factor: 6.106

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.